Naloxone-mediated activation of the hypothalamic–pituitary–adrenal axis in chronic fatigue syndrome
L.V. Scott, F. Burnett, S. Medbak, T.G. Dinan
Background
Opioidergic pathways have an inhibitory regulatory influence on the hypothalamic–pituitary–adrenal axis (HPA) in man. Previous studies...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.